Unraveling oncogenesis: What makes cancer tick?
Recent discoveries in cancer biology may bring forward an additional collection of tools in physicians’ arsenal of cancer therapeutics. Scientists now know that many cancer-associated mutations affect chromatin regulation and the function of multiprotein transcriptional complexes, which can ultimately lead to cancer development and growth. This knowledge may be used to develop future clinical approaches.
The ASBMB annual meeting is around the corner, and attendees can expect a wide variety of symposia offerings throughout the event. One of the symposia, oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer, will focus on the role of transcriptional dysregulation, histone modification and chromatin regulatory complexes in cancer formation. Cigall Kadoch of Harvard Medical School and Greg Wang of Duke University School of Medicine organized and will lead the session.
Wang, a current Journal of Biological Chemistry editorial board member and 2022 ASBMB Young Investigator Award recipient, said the symposium will focus on cancer but encouraged attendees from all fields to participate in the session.
“These topics can be applied to many other diseases as well,” Wang said.
According to Kadoch, the topics covered at the symposium directly relate to patient care and developing novel therapeutic approaches.
“We’re at a unique moment in time in which the learnings from first-in-class approaches in the clinic are coming back to the bench to inform new questions and propel next-step advances,” Kadoch said. “(We) hope this section of the ASBMB meeting does a good job of covering that.”
Wang added: “(This field) elevates basic science to the translational level to ultimately benefit patients.”
Kadoch and Wang selected a diverse array of speakers who study the role of molecular condensates, extrachromosomal DNA, chromatin regulatory machinery, epigenetics and more in cancer.
“I am particularly excited about the interplay of the speakers within the section and the opportunity for our audiences to take away numerous new approaches to exploring some of the most pressing biological questions relating to oncogenic hubs,” Kadoch said.
Check out the full program schedule to get the most out of #ASBMB25.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.
Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.
Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.
ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.
Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.
AI unlocks the hidden grammar of gene regulation
Using fruit flies and artificial intelligence, Julia Zeitlinger’s lab is decoding genome patterns — revealing how transcription factors and nucleosomes control gene expression, pushing biology toward faster, more precise discoveries.